Latest Financials News

Respiri Limited reports a standout December quarter marked by a 67% surge in patient program enrolments and robust revenue growth, bolstered by strategic acquisition synergies from Orb Health. The company is poised for further expansion in 2025 amid promising contract negotiations and evolving US healthcare reimbursement policies.

Galilee Energy reports a $1.9 million R&D tax refund and terminates its merger with Vintage Energy, while maintaining steady progress at its Glenaras Gas Project and a robust cash position of $4.38 million.

Voltaic Strategic Resources has acquired a 4.2% shareholding in Geopacific Resources, gaining strategic exposure to the Woodlark Gold Project in Papua New Guinea, a well-capitalised development with a 12-year mine life and significant exploration upside.

Biotron Limited has engaged US-based C14 Consulting Group to drive strategic partnerships for its antiviral drug portfolio, including lead candidate BIT225, while advancing its Hepatitis B research.

Peako Limited reports compelling exploration results from its East Kimberley projects alongside the granting of new lithium-focused tenements and a successful $1.8 million capital raise.

Amcor plc and Berry Global Group, Inc. have entered into a definitive all-stock merger agreement, positioning the combined entity as a global leader in consumer and healthcare packaging with expected annual synergies of $650 million.

Conrad Asia Energy reports solid progress in Q4 2024 with finalized gas sales agreements and promising LNG studies, despite delayed final investment decisions due to regulatory approvals.

Coventry Group reports a slight dip in H1 FY25 sales but manages a modest EBITDA increase, buoyed by a successful ERP upgrade and strategic growth initiatives.

Amcor plc and Berry Global Group have filed their definitive joint proxy statement with the SEC, marking a key milestone in their planned all-stock merger. Shareholder meetings are scheduled for February 25, 2025, as the companies aim to create a global packaging powerhouse.

Sparc Technologies has committed to Stage 2 of its hydrogen joint venture, secured a pioneering patent in Morocco, and progressed graphene additive trials, signaling momentum in its clean energy and materials innovation.

Paradigm Biopharmaceuticals has secured a $6.3 million R&D Tax Incentive refund, lifting its cash reserves to $31 million and reinforcing its push into Phase 3 osteoarthritis clinical trials.

Barton Gold Holdings reported a $1.74 million net cash outflow from operations in Q4 2024, ending the quarter with $7.01 million in cash and equivalents. The company’s available financing facilities and cash runway suggest cautious optimism for sustaining exploration activities.